Ehlers-Danlos Chronic Pain: Why the Gut Is Part of the Picture

In a global survey of people with hypermobile Ehlers-Danlos syndrome, 98.9% reported chronic pain and 84.3% reported gastrointestinal disorders. They carried a mean of 24 comorbid conditions and waited an average of 22.1 years from first symptom to diagnosis. Ehlers-Danlos chronic pain is usually treated one joint at a time, while the gut, built on the same collagen, gets sent to a different clinic. The video version of Chapter 7 of The Angry Gut, Collagen Is the Wall, Not the Paint, lays out what the gut wall is made of. Here the lens is pain: why a connective-tissue body so often hurts, struggles to digest and runs out of energy all at once, and what a pain practice can do about it.

Ehlers-Danlos chronic pain rarely travels alone

A 2026 meta-analysis pooled the gut data in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder. The odds of chronic gut symptoms were 4.29 times those of controls. Among these patients, 65.3% had at least one chronic gut symptom and 44.2% met criteria for a disorder of gut-brain interaction. Outside the gut, chronic fatigue led at 49%, then migraine at 38.2%, orthostatic intolerance at 35.9% and fibromyalgia at 27.9%. The large survey adds dysautonomia in 71.4%.

That is not a list of unrelated bad luck. It is one tissue problem expressed through the joints, the gut, the blood vessels and the autonomic nervous system at the same time. Pain in this population is multi-organ by nature. A plan that treats only the painful shoulder has treated the least connected part of the patient.

The delay is its own injury. A patient disbelieved for two decades is a patient whose pain went unmanaged for two decades, carrying the shame of normal tests that never explained anything. It is the same trap behind why fibromyalgia test results so often come back normal.

Collagen is structure, not cosmetics

If collagen were decorative, a broken collagen gene would be a skin problem. It is not. Vascular Ehlers-Danlos comes from a defect in type III procollagen, and in a cohort drawn from a diagnostic laboratory, bowel rupture made up about a quarter of all complications. Median survival was 48 years. Among 81 women with the vascular form who became pregnant, pregnancy complications killed 12, and the specific COL3A1 mutation did not predict which catastrophe would arrive.

The mirror image makes the same point from the other side. In collagenous sprue, collagen is laid down in the wrong plane beneath the lining, and absorption collapses. Median age at diagnosis is 65. Where a medication history was recorded, 30 of 38 patients had taken a drug linked to sprue-like injury, most often an angiotensin receptor blocker for blood pressure, and on repeat biopsy 37 of 50 improved. That is a pooled set of case reports, not a risk estimate. It still makes the pill list the first thing to read before anyone calls a bowel problem idiopathic.

The motility result that runs the wrong way

If loose collagen made a loose bowel, a pressure catheter should show it. Researchers ran antroduodenal manometry on 239 consecutive symptomatic patients, 50 with hypermobility and 189 without. Overall dysmotility did not differ, delayed gastric emptying was similar, and enteric dysmotility was actually less common in the hypermobile group, 13% against 34%, p = 0.006.

That result cuts against the tidy mechanism, and it deserves to be said plainly. It came from one tertiary unit, had no healthy comparison group, and measured movement rather than barrier or structure. The symptom pattern agrees with it anyway. The commonest single gut complaint in the meta-analysis was heartburn at 34.7%, the commonest gut-brain disorder was functional dysphagia at 34.2%, and reflux ran 41.3%. That describes a swallow-and-valve problem with symptoms spreading across the body, not a leaking hose. For a pain patient it matters because reflux and difficult swallowing shape what can be eaten, and eating is where tissue repair starts.

A wall rebuilt from what you eat

The gut lining is never a finished structure. It rebuilds continuously on a collagen-rich scaffold, out of material that has to arrive by mouth. When eight healthy volunteers were fed only by vein for 14 days, their total mucosal thickness dropped from 645 to 512 microns, and the lactulose-mannitol ratio, a sugar test of what slips between cells, rose from 0.06 to 0.11.

The detail that matters for anyone in pain is the clock. After five days of food, thickness recovered toward 575 microns, but the leak was still climbing, at 0.14. Structure and function do not heal on the same schedule. Someone who feels no better after a week of eating properly is not failing treatment; the barrier simply lags behind the architecture. Plasma glutamine did not fall during those two weeks of bowel rest either, so a normal blood level said nothing about a thinning lining.

Protein is the raw material, and chewing is a gut problem. When teeth or dentures hurt, protein is the first food to leave the plate. Pain that makes shopping, standing at a stove or sitting at a table hard pushes the same way, and so does eating alone, which is why loneliness counts as a driver of unrelenting pain rather than a side note. Count three ordinary days of protein before anyone orders another scan.

Collagen powder, glutamine and the safety line

Hydrolyzed collagen has a real place in the pain literature, just not in the gut. A systematic review of 36 randomized trials on bone, muscle and joints found joints to be the positive domain, with less pain, better mobility and better ankle function. Muscle results were inconsistent and mostly positive when collagen came paired with exercise. Bone studies were too limited to conclude much, and one author was tied to a collagen ingredient business. The strongest case for the powder is a joint, and the strongest condition is that you also train.

For the gut wall itself, no randomized collagen trial has a gastrointestinal arm, and the barrier claim on the label traces to rats with chemically induced colitis. The exercise half of that equation is not optional in a hypermobile body; read how losing muscle affects the body’s own anti-inflammatory signaling.

Glutamine is the amino acid the rat intestine burns in preference to glucose. In people the results split. A randomized trial in post-infectious irritable bowel syndrome saw 79.6% respond to glutamine against 5.8% on placebo, while ten pooled adult trials of oral glutamine found no change in intestinal permeability. Those two results answer different questions, and the practice works from the mechanism for the patient in the room. But glutamine is not a harmless tonic. In 1,223 critically ill patients with multiorgan failure, it carried a 28-day mortality of 32.4% against 27.2%. The sicker the body, the less casual a supplement is allowed to be, and that decision belongs with your physician.

What a pain practice does with a hypermobile body

The practice position is to treat the tissue and the nervous system together. That means counting protein and fixing the mouth that has to chew it, reading the medication list for anything that could injure the lining, and pairing any collagen use with loading, because that is where the joint evidence lives. It means taking reflux and swallowing seriously as part of the pain picture, and screening for the fatigue, migraine and orthostatic symptoms that travel with this body type instead of filing them under anxiety. Interventional care, where a specific pain generator is found, buys the window in which that rebuilding can happen.

Two biological drivers sit under all of it, a collagen scaffold built wrong and a lining starved of the material to rebuild, and one social driver: a system that takes more than two decades to name the condition while the research money for collagen flows toward skin. The earlier installment, Chapter 6, on the normal B12 that was not normal, covers the stomach machinery that extracts nutrients. Chapter 8, Your Gut Wall Is What You Fried Last Week, turns to the fats in every cell membrane of that wall. For every study here with its full numbers and limits, open the Chapter 7 Deep Dive, where every study sits with its full numbers, its limits and the questions worth asking.

Frequently asked questions

Does Ehlers-Danlos syndrome cause stomach and bowel problems?

Very often. In pooled studies of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder, the odds of chronic gut symptoms were 4.29 times those of controls, and heartburn, reflux and difficulty swallowing were among the most common complaints. That pattern points to the valves and the swallow more than to a slow bowel. Read why the leaky gut test you paid for cannot see the wall.

Why do people with hypermobility have so much pain and fatigue?

Collagen runs through joints, gut and blood vessels, so a collagen disorder shows up across the whole body. In a global survey, 98.9% of people with hypermobile Ehlers-Danlos reported chronic pain and 71.4% reported dysautonomia, and chronic fatigue affected 49% in pooled data. Treating one joint at a time misses the system. See how social isolation acts as an inflammatory state.

Does collagen supplementation help joint pain?

The best collagen evidence is for joints. A systematic review of randomized trials found less joint pain, better mobility and better ankle function, while muscle results were mostly positive only when collagen was combined with exercise. No collagen trial has tested the gut wall in people, so gut claims on the label remain unproven for now. Learn where knee arthritis pain actually comes from.

Is glutamine safe to take for gut symptoms?

It depends on how sick you are. One trial in post-infectious irritable bowel syndrome found a large response, but pooled trials showed no change in gut permeability, and in critically ill patients with multiorgan failure glutamine was linked to higher 28-day mortality. It is not a casual supplement for a seriously unwell body. Discuss it with your physician first. See which agents help rebuild a lining that is being fed.

Can a blood pressure medication affect the gut lining?

It can happen. In collagenous sprue, where collagen builds up beneath the small-bowel lining, 30 of 38 patients with a recorded drug history had taken a medication linked to that injury, most often an angiotensin receptor blocker. That comes from pooled case reports rather than a risk estimate, but a bowel change after a new prescription is worth raising with your physician. Explore other everyday exposures that drive pain.

Sources

1. Kulin, D., Holtmann, G., Fairlie, T., Staller, K., Nurko, S., Keefer, L., Drossman, D. A., Jones, M. P., Talley, N. J., & Ford, A. C. (2026). Meta-analysis: Chronic gastrointestinal symptoms and comorbidities in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Alimentary Pharmacology & Therapeutics, 64(5), 574–589. https://doi.org/10.1111/apt.70856
2. Daylor, V., Griggs, M., Weintraub, A., Byrd, R., Petrucci, T., Huff, M., Byerly, K., Fenner, R., Gensemer, C., Norris, R. A., & Patel, S. (2025). Defining the chronic complexities of hEDS and HSD: A global survey of diagnostic challenges, life-long comorbidities, and unmet needs. Journal of Clinical Medicine, 14(16), 5636. https://doi.org/10.3390/jcm14165636
3. Pepin, M., Schwarze, U., Superti-Furga, A., & Byers, P. H. (2000). Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. The New England Journal of Medicine, 342(10), 673–680. https://doi.org/10.1056/NEJM200003093421001
4. Stirrat, T., Wilkey, M., Kim, S., Waterman, A., & Mattar, M. (2026). Collagenous sprue across five decades (1970-2025): A systematic review. Scandinavian Journal of Gastroenterology, 61(5), 577–585. https://doi.org/10.1080/00365521.2026.2641509
5. Sweerts, K. W. E., Mujagic, Z., Keszthelyi, D., & Conchillo, J. M. (2025). Analysis of antroduodenal motility in patients with hypermobility spectrum disorders/hypermobile Ehlers-Danlos syndrome. Alimentary Pharmacology & Therapeutics, 61(4), 702-705. https://doi.org/10.1111/apt.18471
6. Buchman, A. L., Moukarzel, A. A., Bhuta, S., Belle, M., Ament, M. E., Eckhert, C. D., Hollander, D., Gornbein, J., Kopple, J. D., & Vijayaroghavan, S. R. (1995). Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN. Journal of Parenteral and Enteral Nutrition, 19(6), 453–460. https://doi.org/10.1177/0148607195019006453
7. Brueckheimer, P. J., Costa Silva, T., Rodrigues, L., Zague, V., & Isaia Filho, C. (2025). The effects of type I collagen hydrolysate supplementation on bones, muscles, and joints: A systematic review. Orthopedic Reviews, 17, 129086. https://doi.org/10.52965/001c.129086
8. Zhou, Q., Verne, M. L., Fields, J. Z., Lefante, J. J., Basra, S., Salameh, H., & Verne, G. N. (2019). Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut, 68(6), 996–1002. https://doi.org/10.1136/gutjnl-2017-315136
9. Abbasi, F., Haghighat Lari, M. M., Khosravi, G. R., Mansouri, E., Payandeh, N., & Milajerdi, A. (2024). A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults. Amino Acids, 56(1), 60. https://doi.org/10.1007/s00726-024-03420-7
10. Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013). A randomized trial of glutamine and antioxidants in critically ill patients. The New England Journal of Medicine, 368(16), 1489–1497. https://doi.org/10.1056/NEJMoa1212722

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 7 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP